Since there is no news coming out on the product pipeline until late 2013, we got a verdict today on how the stock is going to behave. Even after that nice Seeking Alpha article, we couldn't maintain the $8 a share. It's a shame. I know I'll be justly rewarded within the next 18 months. I just don't see much of an opportunity to do any trading with this for now.
We should get VMAT results by March or April 2013 and, if positive, it will provide a boost (at least 10 to 20% IMO and maybe more). After that, somehow, someway, we will get an indication of how the Fibroids trial went for Elagolix. My guess is around late next summer we will know something. Obviously, another potential booster if positive. I also believe there will be a run up prior to the VMAT results in anticipation. JMO.
That's true. We could get VMAT results. Also, I do believe that some point in time this stock is going to make a run to 10 bucks a share out of the blue. Some big investors will start piling in prior to the anticipation of endometriosis, fibroids, VMAT2. All that I'm saying is that it sure doesn't look like that going to happen for a while. I'm not going to sell, because the run up would happen the week that I sell! It's tough right now not having any news to look to for the rest of the calendar year.